学科主题临床医学
INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers
Yang, Ruifeng2; Cong, Xu2; Xu, Zhihui1; Xu, Dongping1; Huang, Weijin3; Maertens, Rikkert4; Wei, Lai2
关键词Hepatitis b Virus Genotype Line Probe Assay
刊名CLINICA CHIMICA ACTA
2010-12-14
DOI10.1016/j.cca.2010.08.011
411期:23-24页:1951-1956
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medical Laboratory Technology
研究领域[WOS]Medical Laboratory Technology
关键词[WOS]SURFACE-ANTIGEN ; VIRUS GENOTYPE ; THERAPY ; ASSAY
英文摘要

Background: Different HBV genotypes have effect on the progression and outcome of chronic hepatitis B (CHB) and on the response to antiviral therapy. Accurate and sensitive genotyping methods are needed in clinical practice.

Methods: In this multicenter retrospective study, 504 HBV DNA positive serum or plasma samples of CHB patients or asymptomatic carriers were genotyped by INNO-LiPA HBV genotyping and direct sequencing. A part of the consistent and discrepant results were confirmed by clonal sequencing.

Results: Except two samples with indeterminate results by INNO-LiPA, 463 had the same genotype results by INNO-LiPA and direct sequencing with a concordance of 92.23% (463/502). However 24 had completely inconsistent results by the two methods, seven of which were confirmed by clonal sequencing as the same genotype as by direct sequencing. Fifteen samples were determined as B/C mixed genotypes by INNO-LiPA but singe B or C genotype by direct sequencing, five of which were confirmed by clonal sequencing as B/C mixed infection. Further studies showed INNO-LiPA could detect 6% of genotype B and genotype C among mixed genotype samples at HBV DNA >= 3x10(3) IU/ml.

Conclusions: INNO-LiPA is accurate and sensitive in detecting B, C. D and B/C mixed genotype infection in Chinese CHB patients and asymptomatic carriers. (C) 2010 Elsevier B.V. All rights reserved.

语种英语
WOS记录号WOS:000283916600017
项目编号2005CB522902 ; 2007CB512900 ; 2006AA02A410 ; 30571639 ; 2008ZX10002-012 ; 2008ZX10002-013
资助机构Chinese Basic Research Foundation ; 863 program ; NSFC ; National Science and Technology Key Project ; Ministry of Health
引用统计
被引频次:8[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54121
专题北京大学第二临床医学院_北京大学肝病研究所
作者单位1.302 Hosp PLA, Viral Hepatitis Res Lab, Inst Infect Dis, Beijing 100039, Peoples R China
2.Peking Univ, Inst Hepatol, Peking Univ Peoples Hosp, Beijing 100044, Peoples R China
3.Natl Inst Control Pharmaceut & Biol Prod, Beijing 100050, Peoples R China
4.Innogenetics NV, Hepatitis Diagnost Program, B-9052 Ghent, Belgium
推荐引用方式
GB/T 7714
Yang, Ruifeng,Cong, Xu,Xu, Zhihui,et al. INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers[J]. CLINICA CHIMICA ACTA,2010,411(23-24):1951-1956.
APA Yang, Ruifeng.,Cong, Xu.,Xu, Zhihui.,Xu, Dongping.,Huang, Weijin.,...&Wei, Lai.(2010).INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers.CLINICA CHIMICA ACTA,411(23-24),1951-1956.
MLA Yang, Ruifeng,et al."INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers".CLINICA CHIMICA ACTA 411.23-24(2010):1951-1956.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Yang, Ruifeng]的文章
[Cong, Xu]的文章
[Xu, Zhihui]的文章
百度学术
百度学术中相似的文章
[Yang, Ruifeng]的文章
[Cong, Xu]的文章
[Xu, Zhihui]的文章
必应学术
必应学术中相似的文章
[Yang, Ruifeng]的文章
[Cong, Xu]的文章
[Xu, Zhihui]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。